Literature DB >> 21241727

The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity.

Anup Ramachandran1, Margitta Lebofsky, Steven A Weinman, Hartmut Jaeschke.   

Abstract

UNLABELLED: Acetaminophen (APAP) hepatotoxicity is the most frequent cause of acute liver failure in many countries. The mechanism of cell death is initiated by formation of a reactive metabolite that binds to mitochondrial proteins and promotes mitochondrial dysfunction and oxidant stress. Manganese superoxide dismutase (SOD2) is a critical defense enzyme located in the mitochondrial matrix. The objective of this investigation was to evaluate the functional consequences of partial SOD2-deficiency (SOD2+/-) on intracellular signaling mechanisms of necrotic cell death after APAP overdose. Treatment of C57Bl/6J wild type animals with 200mg/kg APAP resulted in liver injury as indicated by elevated plasma alanine aminotransferase activities (2870±180U/L) and centrilobular necrosis at 6h. In addition, increased tissue glutathione disulfide (GSSG) levels and GSSG-to-GSH ratios, delayed mitochondrial GSH recovery, and increased mitochondrial protein carbonyls and nitrotyrosine protein adducts indicated mitochondrial oxidant stress. In addition, nuclear DNA fragmentation (TUNEL assay) correlated with translocation of Bax to the mitochondria and release of apoptosis-inducing factor (AIF). Furthermore, activation of c-jun-N-terminal kinase (JNK) was documented by the mitochondrial translocation of phospho-JNK. SOD2+/- mice showed 4-fold higher ALT activities and necrosis, an enhancement of all parameters of the mitochondrial oxidant stress, more AIF release and more extensive DNA fragmentation and more prolonged JNK activation.
CONCLUSIONS: the impaired defense against mitochondrial superoxide formation in SOD2+/- mice prolongs JNK activation after APAP overdose and consequently further enhances the mitochondrial oxidant stress leading to exaggerated mitochondrial dysfunction, release of intermembrane proteins with nuclear DNA fragmentation and more necrosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241727      PMCID: PMC3050115          DOI: 10.1016/j.taap.2011.01.004

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  54 in total

1.  Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3'-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Y Qiu; L Z Benet; A L Burlingame
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

Review 2.  Degradation of chromosomal DNA during apoptosis.

Authors:  S Nagata; H Nagase; K Kawane; N Mukae; H Fukuyama
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

3.  Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2.

Authors:  M L Adams; R H Pierce; M E Vail; C C White; R P Tonge; T J Kavanagh; N Fausto; S D Nelson; S A Bruschi
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

4.  Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8.

Authors:  M L Bajt; J A Lawson; S L Vonderfecht; J S Gujral; H Jaeschke
Journal:  Toxicol Sci       Date:  2000-11       Impact factor: 4.849

5.  Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione.

Authors:  Tamara R Knight; Ye-Shih Ho; Anwar Farhood; Hartmut Jaeschke
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

6.  Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress.

Authors:  T R Knight; A Kurtz; M L Bajt; J A Hinson; H Jaeschke
Journal:  Toxicol Sci       Date:  2001-08       Impact factor: 4.849

7.  Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?

Authors:  Jaspreet S Gujral; Tamara R Knight; Anwar Farhood; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2002-06       Impact factor: 4.849

8.  Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury.

Authors:  Anup Ramachandran; Margitta Lebofsky; Christopher P Baines; John J Lemasters; Hartmut Jaeschke
Journal:  Free Radic Res       Date:  2010-10-13

Review 9.  Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression.

Authors:  Igor N Zelko; Thomas J Mariani; Rodney J Folz
Journal:  Free Radic Biol Med       Date:  2002-08-01       Impact factor: 7.376

Review 10.  The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity.

Authors:  Hartmut Jaeschke; Tamara R Knight; Mary Lynn Bajt
Journal:  Toxicol Lett       Date:  2003-10-15       Impact factor: 4.372

View more
  56 in total

1.  Novel protective mechanisms for S-adenosyl-L-methionine against acetaminophen hepatotoxicity: improvement of key antioxidant enzymatic function.

Authors:  James Michael Brown; John G Ball; Michael Scott Wright; Stephanie Van Meter; Monica A Valentovic
Journal:  Toxicol Lett       Date:  2012-06-05       Impact factor: 4.372

2.  Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury.

Authors:  Yuchao Xie; Anup Ramachandran; David G Breckenridge; John T Liles; Margitta Lebofsky; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-25       Impact factor: 4.219

3.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 4.  Novel Therapeutic Approaches Against Acetaminophen-induced Liver Injury and Acute Liver Failure.

Authors:  Hartmut Jaeschke; Jephte Y Akakpo; David S Umbaugh; Anup Ramachandran
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

5.  RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.

Authors:  Daniel J Antoine; Rosalind E Jenkins; James W Dear; Dominic P Williams; Mitchell R McGill; Matthew R Sharpe; Darren G Craig; Kenneth J Simpson; Hartmut Jaeschke; B Kevin Park
Journal:  J Hepatol       Date:  2012-01-17       Impact factor: 25.083

6.  Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity.

Authors:  Mary Lynn Bajt; Anup Ramachandran; Hui-Min Yan; Margitta Lebofsky; Anwar Farhood; John J Lemasters; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2011-05-13       Impact factor: 4.849

7.  Response to the opinion letter entitled Role of Ferroptosis in Acetaminophen Hepatotoxicity by Yamada et al.

Authors:  Hartmut Jaeschke; Anup Ramachandran
Journal:  Arch Toxicol       Date:  2020-04-02       Impact factor: 5.153

8.  Cytochrome P450-derived versus mitochondrial oxidant stress in acetaminophen hepatotoxicity.

Authors:  Hartmut Jaeschke; Mitchell R McGill
Journal:  Toxicol Lett       Date:  2015-04-06       Impact factor: 4.372

9.  Oxidative Stress and Acute Hepatic Injury.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Curr Opin Toxicol       Date:  2018-02

10.  Editor's Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and Dysfunction.

Authors:  Kuo Du; Anup Ramachandran; James L Weemhoff; Hemantkumar Chavan; Yuchao Xie; Partha Krishnamurthy; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2016-08-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.